Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 9/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.59 |
| ▸ | LMNA | P02545 | 6/20 | 0.59 |
| ▸ | HTT | P42858 | 3/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.58 |
| ▸ | HPGD | P15428 | 6/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.58 |
| ▸ | PGR | P06401 | 1/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.58 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.58 |
| ▸ | PDE4A | P27815 | 1/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.58 |
| ▸ | HRH1 | P35367 | 1/20 | 0.58 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.58 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6112746 | 0.98 | MAPT (0.58) | MAPTKDM4EHSD17B10MAPK1ALOX15 | |
| SCHEMBL7767220 | 0.88 | MAPT (0.60) | MAPTKDM4EHSD17B10MAPK1ALOX15 | |
| SCHEMBL25381912 | 0.87 | MAPT (0.64) | MAPTKDM4EHSD17B10MAPK1ALOX15 | |
| SCHEMBL9339159 | 0.85 | MAPT (0.77) | MAPTKDM4EHSD17B10MAPK1ALOX15 | |
| SCHEMBL19003473 | 0.83 | HDAC1 (0.64) | MAPTKDM4EHSD17B10MAPK1ALOX15 | |
| SCHEMBL28716348 | 0.83 | MAPT (0.55) | MAPTKDM4EHSD17B10MAPK1ALOX15 | |
| SCHEMBL480277 | 0.82 | MAPT (0.60) | MAPTKDM4EHSD17B10MAPK1ALOX15 | |
| SCHEMBL27976994 | 0.82 | MAPT (0.60) | MAPTKDM4EHSD17B10MAPK1ALOX15 | |
| SCHEMBL302637 | 0.81 | LMNA (0.55) | MAPTKDM4EHSD17B10MAPK1ALOX15 | |
| SCHEMBL29709425 | 0.81 | MAPT (0.59) | MAPTKDM4EHSD17B10MAPK1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110739404-B | Quantum dot light-emitting diode and preparation method thereof | TCL科技集团股份有限公司 | 2021-04-02 | — | — | CN | claimed |
| CN-101316577-B | Personal care compositions containing silicone resins with enhanced properties and methods of making and using the same | MOMENTIVE PERFORMANCE MAT INC | 2015-07-15 | — | — | CN | claimed |
| CN-101316577-A | Personal care compositions containing silicone resins with enhanced properties and methods of making and using the same | MOMENTIVE PERFORMANCE MAT INC (US) | 2008-12-03 | — | — | CN | claimed |
| CN-1518469-A | Dermatological preparations | �����ɷ� | 2004-08-04 | — | — | CN | claimed |
| CN-122005622-A | Composition for improving, preventing or treating vaginitis or vulvitis comprising lactobacillus salivarius HHuMin-U | 比菲德股份有限公司 | 2026-05-12 | — | — | CN | disclosed |
| US-12616730-B2 | Topical composition comprising an extract of combined herbs comprising longanae arillus for the treatment or alleviation of skin ulcer and the use thereof | MEDIHELPLINE CO., LTD (KR) | 2026-05-05 | — | — | US | disclosed |
| CN-115337242-B | Traditional Chinese medicine composition, extract, preparation method and application thereof, cosmetics and medicines | 上海如妍化妆品有限公司 | 2025-03-21 | — | — | CN | disclosed |
| US-20250057872-A1 | INNATE IMMUNOMODULATORY EFFECT OF GINSENG BERRY POLYSACCHARIDES IN IMMUNOCOMPROMISED CONDITIONS | Gangneung-Wonju National University Industry Academy Cooperation Group (KR) | 2025-02-20 | — | — | US | disclosed |
| US-20240398692-A1 | MANUFACTURING METHOD OF COFFEE CELL AND ADVENTITIOUS ROOT CULTURE COMPRISING INCREASED BIOACTIVE SUBSTANCES AND USE THEREOF | BIO-FD&C (KR) | 2024-12-05 | — | — | US | disclosed |
| US-20240285714-A1 | COMPOSITION FOR ANTI-INFLAMMATORY, ANTIOXIDANT, ANTI-WRINKLE OR HAIR HEALTH PROMOTION CONTAINING EXTRACT MIXTURE OF ZIZIPHUS JUJUBA MILLER, CITRUS UNSHIU PEEL AND ACORUS CALAMUS AS ACTIVE INGREDIENT | INDUSTRY-ACADEMIC COOPERATION FOUNDATION DAEGU HAANY UNIVERSITY (KR) | 2024-08-29 | — | — | US | disclosed |
| CN-118161520-A | Lipolytic composition using surface-modified gas-generating nanoparticles | 超新星生物有限公司 | 2024-06-11 | — | — | CN | disclosed |
| CN-115137664-B | Cosmetic composition for improving skin activity containing Astragalus membranaceus peptide maturation matter | 株式会社现代百朗德 | 2024-05-17 | — | — | CN | disclosed |
| EP-1438423-A1 | ENZYME ACTIVITY INDICATORS | Burton, Michael (GB) | 2004-07-21 | — | — | EP | disclosed |
| WO-2004017982-A1 | COMPOSITION COMPRISING THE EXTRACT OF ACTINIDIA ARGUTA AND RELATED SPECIES FOR THE PREVENTION AND TREATMENT OF ALLERGIC DISEASE AND NON-ALLERGIC INFLAMMATORY DISEASE | PANGENOMICS CO., LTD (KR) | 2004-03-04 | — | — | WO | disclosed |
| US-20040037909-A1 | Composition comprising the extract of actinidia arguta and related species for the prevention and treatment of allergic disease and non-allergic inflammatory disease | VIROMED CO., LTD. (KR) | 2004-02-26 | — | — | US | disclosed |
| US-20030199660-A1 | Silicone polymer, silicone composition, and cosmetic preparation containing the same | SHIN-ETSU CHEMCIAL CO., LTD. (JP) | 2003-10-23 | — | — | US | disclosed |
| WO-2003035900-A1 | ENZYME ACTIVITY INDICATORS | BURTON MICHAEL (GB) | 2003-05-01 | — | — | WO | disclosed |
| EP-1291376-A1 | SILICONE POLYMER, SILICONE COMPOSITION, AND COSMETIC PREPARATION CONTAINING THE SAME | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2003-03-12 | — | — | EP | disclosed |
| CN-1328813-A | Cosmetics | KYOWA HAKKO KOGY CO LTD (JP) | 2002-01-02 | — | — | CN | disclosed |
| WO-1999062889-A1 | NOVEL 8-AMINO-1,4-BENZOXAZINE COMPOUNDS, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ADIR ET COMPAGNIE (FR) | 1999-12-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12616730-B2 | Topical composition comprising an extract of combined herbs comprising longanae arillus for the treatment or alleviation of skin ulcer and the use thereof | CUTA, VEGFA, MMP8 | MAPT 3161/4885KDM4E 2491/4885HSD17B10 3652/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.